Skip to main content
NCBI home page
Canadian Family Physician logoLink to Canadian Family Physician
. 1991 Jan;37:109–118.

Adverse Drug Reactions

Review of the Canadian literature

Joel Lexchin
PMCID: PMC2145131  PMID: 21234084

Abstract

A combined manual and computer search of the literature on the Canadian experience with adverse drug reactions (ADRs) to prescribed drugs yielded a total of 23 articles. The risk of developing an ADR, factors influencing that risk, the incidence of ADRs, ADRs as a cause of hospitalization, case fatality ratios, whether ADRs increase hospitalization time, and the drugs that are most commonly implicated in ADRs were analyzed.

Full text

PDF
109

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aranda J. V., Portuguez-Malavasi A., Collinge J. M., Germanson T., Outerbridge E. W. Epidemiology of adverse drug reactions in the newborn. Dev Pharmacol Ther. 1982;5(3-4):173–184. [PubMed] [Google Scholar]
  2. Borda I. T., Napke E., Stapleton C. Drug surveillance data in a Canadian hospital. Can Med Assoc J. 1976 Mar 20;114(6):517–522. [PMC free article] [PubMed] [Google Scholar]
  3. Gowdey C. W., Brennan M. Adverse Drug Reaction Reporting Program of the Ontario Medical Association: the first 3 years. Can Med Assoc J. 1985 Jan 1;132(1):19–23. [PMC free article] [PubMed] [Google Scholar]
  4. Grymonpre R. E., Mitenko P. A., Sitar D. S., Aoki F. Y., Montgomery P. R. Drug-associated hospital admissions in older medical patients. J Am Geriatr Soc. 1988 Dec;36(12):1092–1098. doi: 10.1111/j.1532-5415.1988.tb04395.x. [DOI] [PubMed] [Google Scholar]
  5. Hoddinott B. C., Gowdey C. W., Coulter W. K., Parker J. M. Drug reactions and errors in administration on a medical ward. Can Med Assoc J. 1967 Oct 21;97(17):1001–1006. [PMC free article] [PubMed] [Google Scholar]
  6. Hutchinson T. A., Flegel K. M., Kramer M. S., Leduc D. G., Kong H. H. Frequency, severity and risk factors for adverse drug reactions in adult out-patients: a prospective study. J Chronic Dis. 1986;39(7):533–542. doi: 10.1016/0021-9681(86)90198-0. [DOI] [PubMed] [Google Scholar]
  7. Karch F. E., Lasagna L. Adverse drug reactions. A critical review. JAMA. 1975 Dec 22;234(12):1236–1241. [PubMed] [Google Scholar]
  8. Karch F. E., Smith C. L., Kerzner B., Mazzullo J. M., Weintraub M., Lasagna L. Adverse drug reactions-a matter of opinion. Clin Pharmacol Ther. 1976 May;19(5 Pt 1):489–492. doi: 10.1002/cpt1976195part1489. [DOI] [PubMed] [Google Scholar]
  9. Koch-Weser J., Sidel V. W., Sweet R. H., Kanarek P., Eaton A. E. Factors determining physician reporting of adverse drug reactions. Comparison of 2000 spontaneous reports with surveillance studies at the Massachusetts General Hospital. N Engl J Med. 1969 Jan 2;280(1):20–26. doi: 10.1056/NEJM196901022800105. [DOI] [PubMed] [Google Scholar]
  10. Kramer M. S., Leventhal J. M., Hutchinson T. A., Feinstein A. R. An algorithm for the operational assessment of adverse drug reactions. I. Background, description, and instructions for use. JAMA. 1979 Aug 17;242(7):623–632. [PubMed] [Google Scholar]
  11. Mikhael N. Z., Kacew S. Adverse tissue reactions to drugs: a five-year surveillance study. Hum Toxicol. 1985 Nov;4(6):583–590. doi: 10.1177/096032718500400604. [DOI] [PubMed] [Google Scholar]
  12. Mikhael N. Z., Kacew S. Monitoring of adverse drug reactions by means of autopsy tissue examination. Hum Toxicol. 1984 Apr;3(2):133–140. doi: 10.1177/096032718400300206. [DOI] [PubMed] [Google Scholar]
  13. Napke E., Stevens D. G. Excipients and additives: hidden hazards in drug products and in product substitution. Can Med Assoc J. 1984 Dec 15;131(12):1449–1452. [PMC free article] [PubMed] [Google Scholar]
  14. Ogilvie R. I., Ruedy J. Adverse drug reactions during hospitalization. Can Med Assoc J. 1967 Dec 9;97(24):1450–1457. [PMC free article] [PubMed] [Google Scholar]
  15. Reynolds J. L. A survey of adverse drug reactions in family practice. Can Fam Physician. 1984 Jan;30:81–84. [PMC free article] [PubMed] [Google Scholar]
  16. Soon J. A. Assessment of an adverse drug reaction monitoring program in nursing homes. Can J Hosp Pharm. 1985 Aug;38(4):120–125. [PubMed] [Google Scholar]
  17. Soon J. A. Developing an adverse drug reaction program in nursing homes. Can J Hosp Pharm. 1980 Sep-Oct;33(5):158-61, 164. [PubMed] [Google Scholar]
  18. Spino M., Sellers E. M., Kaplan H. L. Effect of adverse drug reactions on the length of hospitalization. Am J Hosp Pharm. 1978 Sep;35(9):1060–1064. [PubMed] [Google Scholar]
  19. Spino M., Sellers E. M., Kaplan H. L., Stapleton C., MacLeod S. M. Adverse biochemical and clinical consequences of furosemide administration. Can Med Assoc J. 1978 Jun 24;118(12):1513–1518. [PMC free article] [PubMed] [Google Scholar]
  20. Taras-Zasowski K. M., Einarson T. R. Review of Canadian pharmacist involvement in adverse drug reaction reporting. Can J Hosp Pharm. 1989 Jun;42(3):105-8, 133. [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES